WASHINGTON, June 20, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that its wholly-owned subsidiary, DH Europe Finance S.A. (“Danaher International”), has priced an offering of: €250 million principal amount of floating rate senior notes due 2022 at an offering price of 100.147% of the principal amount; and €600 million principal amount of... Read more
WASHINGTON, June 8, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, and Executive Vice President Rainer Blair will be presenting at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, California on Wednesday, June 14, 2017 at 10:00 a.m. PT. The audio will... Read more
WASHINGTON, May 25, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Bernstein Strategic Decisions Conference in New York City on Thursday, June 1, 2017 at 8:00 a.m. ET. The audio will be simultaneously webcast and the presentation will be archived... Read more
WASHINGTON, May 15, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Electrical Products Group Conference in Longboat Key, Florida on Monday, May 22, 2017 at 10:00 a.m. ET. The audio will be simultaneously webcast and the presentation will be archived on... Read more
WASHINGTON, May 10, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada on Wednesday, May 17, 2017 at 9:20 a.m. PT. The audio will be simultaneously webcast on www.danaher.com. ... Read more
SCIEX features its ground-breaking biologics solutions including the X500B QTOF System and the Fast Glycan Labeling and Analysis Kit April 11, 2017 Framingham, MA — SCIEX, a Danaher company and global leader in life science analytical technologies, today announced that it presented the company’s latest ground-breaking biologics solutions at the Danaher Life Sciences Biologics Day.... Read more
Danaher Announces Appointment of Raymond C. Stevens, Ph.D. to Danaher Board WASHINGTON, Feb. 21, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it has appointed Raymond C. Stevens, Ph.D. to its Board of Directors. Professor Stevens is currently Provost Professor of Biological Sciences and Chemistry, and Director of The Bridge Institute, at the... Read more
WASHINGTON, Feb. 16, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Barclays Industrial Select Conference in Miami, Florida on Thursday, February 23, 2017 at 9:10 a.m. ET. The audio will be simultaneously webcast on www.danaher.com. About Danaher Danaher is a... Read more
Danaher To Present At J.P. Morgan Healthcare Conference WASHINGTON, Jan. 4, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 10, 2017 at 11:30 a.m. PT. The audio will be simultaneously... Read more
WASHINGTON, Dec. 1, 2016 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that effective January 1, 2017, Rainer Blair has been promoted to Executive Vice President of Danaher Corporation, with responsibility for the Company’s $5 billion Life Sciences platform. Mr. Blair, 52 years old, has served in a series of progressively more responsible general management... Read more